Compounds for the Treatment of Kinase-Dependent Disorders

Disclosed herein are compounds of Formula (I) which inhibit, regulate and/or modulate tyrosine kinase receptors, particularly Ax1 and Mer signal transduction pathways related to the changes in cellular activities, compositions containing the compounds, methods of using the compounds to treat kinase-...

Full description

Saved in:
Bibliographic Details
Main Authors Wang, Yong, Bui, Minna, Xu, Wei, Jiang, Faming, Tso, Kin, Bannen, Lynne Canne
Format Patent
LanguageEnglish
Published 09.02.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are compounds of Formula (I) which inhibit, regulate and/or modulate tyrosine kinase receptors, particularly Ax1 and Mer signal transduction pathways related to the changes in cellular activities, compositions containing the compounds, methods of using the compounds to treat kinase-dependent diseases and conditions, and methods for making the compounds.
Bibliography:Application Number: US202017616120